Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.
Report Code : A02925 | Category : Life Sciences
Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is ...
Report Code : A03515 | Category : Life Sciences
This report is a comprehensive study of current trends, industry growth drivers, and restraints in the market. In addition, the study provides regional information ...
Report Code : A112132 | Category : Life Sciences
The global recombinant proteins market was valued at $2.5 billion in 2023, and is projected to reach $5.2 billion by 2033, growing at a CAGR of 7.7% from 2024 to 2033.
Report Code : A11233 | Pages : 405 | Category : Life Sciences
Market Snapshot
The Recombinant albumin market report offers an in-depth ...
Report Code : A114684 | Category : Life Sciences
The report provides in-depth analysis of the market, outlining current ...
Report Code : A119839 | Category : Life Sciences
The report on global Recombinant factor viii market provides an in-depth insight on current trends, market dynamics, challenges, and opportunity. In addition, it offers ...
Report Code : A124611 | Category : Life Sciences
Recombinant factor C is a non-animal-derived reagent used to detect endotoxins in various pharmaceutical products. Furthermore, recombinant factor C assay test is a new age alternative test against ...
Report Code : A13438 | Category : Life Sciences
Report Summary
The report aims to provide detailed insights on ...
Report Code : A174226 | Category : Life Sciences
Report Summary
The report aims to provide detailed insights on ...
Report Code : A174286 | Category : Life Sciences
Market Snapshot
The report provides quantitative and qualitative analysis of ...
Report Code : A174660 | Category : Life Sciences
Report Overview
The report provides an in-depth study of factors, such ...
Report Code : A174663 | Category : Life Sciences
The global recombinant vaccines market was valued at $8.1 billion in 2021, and is projected to reach $24.7 billion by 2031, growing at a CAGR of 11.4% from 2022 to 2031.
Report Code : A17605 | Pages : 258 | Category : Life Sciences
A new study on Global Recombinant antihemophilic factor market reveals upcoming trends, revenue opportunities, and market forecast: Allied ...
Report Code : A177729 | Category : Life Sciences
Major Advantages The report under production by Allied Market Research on the Recombinant human serum albumin market offers a comprehensive study of global market size & forecast, country-level outlook, segmental analysis, market opportunities,
Report Code : A19500 | Category : Life Sciences
Report Overview
The report highlights numerous factors that influence the growth of the global Recombinant follicle stimulating hormone market such as ...
Report Code : A197923 | Category : Life Sciences
Market Snapshot
The report provides quantitative and qualitative analysis of ...
Report Code : A201649 | Category : Life Sciences
Market Snapshot
The Recombinant erythropoietin market report offers an in-depth ...
Report Code : A209577 | Category : Life Sciences
An Overview
The report offers a ...
Report Code : A212424 | Category : Life Sciences
Market Snapshot
The report provides quantitative and qualitative analysis of ...
Report Code : A227051 | Category : Life Sciences
The global Recombinant immunotherapeutics market is analyzed on the basis of its current/ongoing ...
Report Code : A236496 | Category : Life Sciences
Scope of the Study
The Recombinant fviii market study presents an ...
Report Code : A236623 | Category : Life Sciences
Scope of the Study
The Recombinant human papillomavirus 9-valent vaccine market study presents an ...
Report Code : A285173 | Category : Life Sciences
Report Summary
The scope of the report focuses on the potential ...
Report Code : A289195 | Category : Life Sciences
An Overview
The report covers a study of by product type, by application, by distribution channel. Region wise, the Recombinant non-glycosylated ...
Report Code : A291580 | Category : Life Sciences
